Archive for the ‘Medical Hazards’ Category

Tell Me Again: Properly Filtered Bottled Water Is No Better Than Tap Water?

Tuesday, September 16th, 2008

There has been a good deal of hoopla recently about the absurdity of drinking filtered, bottled, or other wise special water. It is more expensive (true), it has plasticizers in the water from the most commonly used type of bottles and these confer dangers (true) and it is unnecessary since municipal water in the US is safe and wholesome (manifestly untrue). The article posted below makes it very clear that the water you drink from municipal supplies can kill you, or at least change your biology significantly, whether you want it to or not.
I agree, as an environmentally aware physician, that plastic bottles are dangerous. Bis-Phalates are bad for you. I also agree that water which is merely put into jugs and bottles from common municiple taps are absurd, deceptive and should be clearly labled, “Nothing but tap water at a premium – no charge for the plasticizers”.
But the notion that water supplies in the US are anything close to safe is patently absurd. Water is frequently poisoned, yes, poisoned, with fluoride compounds (often derived from uranium mining but too expensive to dispose of according to EPA standards, so it is more profitably sold), chlorine, aluminum (to “polish” the water and give it sparkle) and a host of other unwise and dangerous compounds.
So yes, the bacteria that are tested for, including E. coli, a component of human and animal feces which is uses as an index organism (that is, if it is present, so are other dangerous components of feces), which were those of concern when water purification became a public responsibility in the late 18, early 19th century, are not present, mostly, in the water supply of most municipalities.
But benzine and other industrail wastes, pesticides, herbicides, waste-water emissions from nuclear stations which can legally (!) be discharged into water ways, land fill leachates, acid rain-dissolved chemicals and compounds legally and illegallly dumped, etc., etc., etc., plus the lead from the solder used on the water pipes in places like New York City (!) make unfiltered municipal water a highly dangerous bet for drinking, cooking or sterilizing.
You see, bacteria were of major concern. But the standards for metals, industrial compounds (which did not even exist when purification was being standardized, and a host of recent problems makes the quality of water, aside from its bacteria-free status, highly problematic, indeed.
Plastic is a serious concern, it is true. Use glass. Buy bottles of stuff in heavy glass, dump it out, wash the bottles out and use them instead of plastic to hold the water you filter with heavy duty, NOT pitcher-type filters. I prefer reverse osmosis filters with the capacity to add minerals back in. But clean water in glass bottles is essential for life, health and well-being.

And then there are the pharmaceuticals. See below!
Yours in health and freedom,
Dr. Rima
Rima E. Laibow, MD
Medical Director
Natural Solutions Foundation
www.HealthFreedomUSA.org
www.GlobalHealthFreedom.org
www.NaturalSolutionsFoundation.org
www.Organics4U.org
www.NaturalSolutionsMedia.tv
www.NaturalSolutionsMarketPlace.org

bottlesTons of Drugs Dumped Into Wastewater
https://mail.google.com/mail/?ui=2&ik=afbdc5dc14&attid=0.0.1.2&disp=emb&view=att&th=11c6a797e3776720
Bryant Sears, working in a Teflon suit and wearing goggles and rubber gloves, sorts leftover medicines and contaminated packing one-by-one at Abbott Northwestern Hospital, May 13, 2008 in Minneapolis. Items are put into separate barrels and bins, depending on their differing disposal standards and methods. (AP Photo/Jim Mone)

by Jeff Donn Martha Mendoza and Justin Pritchard

U.S. hospitals and long-term care facilities annually flush millions of pounds of unused pharmaceuticals down the drain, pumping contaminants into America’s drinking water, according to an ongoing Associated Press investigation.
[Bryant Sears, working in a Teflon suit and wearing goggles and rubber gloves, sorts leftover medicines and contaminated packing one-by-one at Abbott Northwestern Hospital, May 13, 2008 in Minneapolis. Items are put into separate barrels and bins, depending on their differing disposal standards and methods. (AP Photo/Jim Mone)]Bryant Sears, working in a Teflon suit and wearing goggles and rubber gloves, sorts leftover medicines and contaminated packing one-by-one at Abbott Northwestern Hospital, May 13, 2008 in Minneapolis. Items are put into separate barrels and bins, depending on their differing disposal standards and methods. (AP Photo/Jim Mone)
These discarded medications are expired, spoiled, over-prescribed or unneeded. Some are simply unused because patients refuse to take them, can’t tolerate them or die with nearly full 90-day supplies of multiple prescriptions on their nightstands.

Few of the country’s 5,700 hospitals and 45,000 long-term care homes keep data on the pharmaceutical waste they generate. Based on a small sample, though, the AP was able to project an annual national estimate of at least 250 million pounds of pharmaceuticals and contaminated packaging, with no way to separate out the drug volume.

One thing is clear: The massive amount of pharmaceuticals being flushed by the health services industry is aggravating an emerging problem documented by a series of AP investigative stories – the commonplace presence of minute concentrations of pharmaceuticals in the nation’s drinking water supplies, affecting at least 46 million Americans.

Researchers are finding evidence that even extremely diluted concentrations of pharmaceutical residues harm fish, frogs and other aquatic species in the wild. Also, researchers report that human cells fail to grow normally in the laboratory when exposed to trace concentrations of certain drugs.

The original AP series in March prompted federal and local legislative hearings, brought about calls for mandatory testing and disclosure, and led officials in more than two dozen additional metropolitan areas to analyze their drinking water.

And while most pharmaceutical waste is unmetabolized medicine that is flushed into sewers and waterways through human excretion, the AP examined institutional drug disposal and its dangers because unused drugs add another substantial dimension to the problem.

“Obviously, we’re flushing them – which is not ideal,” acknowledges Mary Ludlow at White Oak Pharmacy, a Spartanburg, S.C., firm that serves 15 nursing homes and assisted-living residences in the Carolinas.

Such facilities, along with hospitals and hospices, pose distinct challenges because they handle large quantities of powerful and toxic drugs – often more powerful and more toxic than the medications people use at home. Tests of sewage from several hospitals in Paris and Oslo uncovered hormones, antibiotics, heart and skin medicines and pain relievers.

Hospital waste is particularly laden with both germs and antibiotics, says microbiologist Thomas Schwartz at Karlsruhe Research Center in Germany.

The mix is a scary one.

In tests of wastewater retrieved near other European hospitals and one in Davis County, Utah, scientists were able to link drug dumping to virulent antibiotic-resistant germs and genetic mutations that may promote cancers, according to scientific studies reviewed by the AP.

Researchers have focused on cell-poisoning anticancer drugs and fluoroquinolone class antibiotics, like anthrax fighter ciprofloxacin.

At the University of Rouen Medical Center in France, 31 of 38 wastewater samples showed the ability to mutate genes. A Swiss study of hospital wastewater suggested that fluoroquinolone antibiotics also can disfigure bacterial DNA, raising the question of whether such drug concoctions can heighten the risk of cancer in humans.

Pharmacist Boris Jolibois, one of the French researchers at Compiegne Medical Center, believes hospitals should act quickly, even before the effects are well understood. “Something should be done now,” he said. “It’s just common sense.”

___

Some contaminated packaging and drug waste are incinerated; more is sent to landfills. But it is believed that most unused pharmaceuticals from health care facilities are dumped down sinks or toilets, usually without violating state or federal regulations.

The Environmental Protection Agency told assembled water experts last year that it believes nursing homes and other long-term care facilities use sewer systems to dispose of most of their unused drugs. A water utility surveyed 45 long-term care facilities in 2006 and calculated that two-thirds of their unused drugs were scrapped this way, according to the National Association of Clean Water Agencies.

An internal EPA memo last year included pharmaceuticals on a list of “major pollutants of concern” at health care businesses. Still, few medical centers keep comprehensive records of drugs they cast down toilets or into landfills. When data are kept, drugs and tainted packaging are combined in the same totals.

In an attempt to quantify the problem, the AP examined records in Minnesota, where state regulators have pushed hospital administrators to keep closer track than elsewhere. Fourteen facilities were surveyed, in a range of settings from rural to urban. The AP projected those annual totals onto the national patient population for hospitals and adjusted for the relatively lower pharmaceutical use of Minnesotans. Since long-term care facilities generate more drug waste than hospitals, the AP conservatively doubled the number.

That calculation produced an estimate of at least 250 million pounds of annual drug waste from hospitals and long-term care centers, further complicated by the fact experts say drugs might account for only up to half of pharmaceutical waste, while the rest is packaging.

The AP estimate excludes many other sources of health industry drug waste, from doctors’ to veterinary offices. Smaller medical offices typically dispose of expired samples and unwanted drugs like ordinary consumers – with little forethought.

Alan Davidner, president of Vestara of Irvine, Calif., which sells systems to manage drug waste, says his limited sampling suggests the health care industry’s contribution could even be higher.

Plus, untold amounts of pills and tablets are being thrown away each year at federal and state correctional institutions.

At a state prison in Oak Park Heights, Minn., nurse Linda Peterson says the hospital unit serving inmates statewide has been throwing away up to 12,000 pills a year. She says some heart medicines and antibiotics are simply chucked into the trash. Tightly regulated narcotics susceptible to abuse go down the toilet.

“We flush it and flush it and flush it – until we can’t see any more pills,” she says.

She notes the presence of nursing homes, a hospital and another prison in the same area. “So what are all these facilities doing, if we’re throwing away about 700 to 1,000 pills a month?”

___

The EPA is considering whether to impose the first national standard for how much drug waste may be released into waterways by the medical services industry, but Ben Grumbles, the EPA’s top water administrator, says a decision won’t be made until next year, at the earliest.

So far, regulators have done little more than politely ask the medical care industry to stop pouring drugs into the wastewater system. “Treating the toilet as a trash can isn’t a good option,” says Grumbles.

Some think it’s time to do more than ask. “It’s strange that we have rules about the oil from your car; you’re not allowed to simply flush it down the sewer,” says U.S. Rep. Tim Murphy, R-Pa. “So why do we let these drugs, without any kind of regulation, continue to be flushed away in the water supply?”

Landfills are one alternative. At least they don’t empty directly, and immediately, into waterways like some sewage.

Marjorie E. Powell, a lawyer for the Pharmaceutical Research and Manufacturers of America, says landfills are “more environmentally friendly,” while EPA spokeswoman Roxanne Smith contends that landfilling of hazardous pharmaceutical waste “poses little threat to the public.”

Still, Grumbles acknowledges that landfills, while safer, are not a permanent solution. That’s because pharmaceuticals can eventually reach waterways from landfills through leaks or intentional releases of treated seepage known as leachate.

An agency staffer wrote in a memo last year: “EPA recognizes that residuals in the leachate could contaminate groundwater supplies and ultimately reach water treatment plants, but disposal into the trash is currently considered a BMP” – or best management practice.

Already, researchers have detected trace concentrations of drugs – including the pain reliever ibuprofen and seizure medicine carbamazepine – in seepage or groundwater near landfills.

Environmental professionals outside government are reaching a consensus that incinerators are the best disposal method.

“That’s the best practice for today because we don’t really know what the hell to do with the stuff,” says industrial engineer Laura Brannen, an executive at Waste Management Healthcare Solutions, of Houston. She says burning destroys more drug waste than all other methods, though some contaminants may escape in smoke and ash.

On a recent day at Abbott Northwestern Hospital in Minneapolis, Mary Kuch was getting ready to squirt leftovers from a syringe of hydromorphone, a powerful morphine derivative, into a sink. When she started out in nursing 18 years ago, “I took it for granted, because I was a young nurse, and that’s what other nurses did,” she says. “But I did find it strange.”

These days, only four gallons – drugs with high potential for abuse – go down the hospital’s drains each year. Nearly all leftover medicine and contaminated packaging are instead tossed into black bins and rolled to a hospital storage room crammed with scores of 55-gallon drums.

There, waste-company employee Bryant Sears – dressed in a Teflon suit, rubber gloves and goggles – conducts a sorting operation. Pills, blister packs and liquid medicines collected in vials, along with syringes and IV bags, are separated out according to differing disposal standards and methods. Occasionally, he glances at a wall-sized placard with details on which drug goes where – hazardous waste in one barrel, nonhazardous in another. A roll of “hazardous waste” stickers hangs from a pole on the wall.

Sears points to some epinephrine, a heart drug, saying, “Now that it’s past its expiration date, it’s waste.”

These leftovers and discards ultimately will be incinerated.

EPA’s Smith says even municipal burners unapproved for hazardous waste “will destroy all but a minute fraction” of organic compounds – the kind found in pharmaceuticals.

But Stephen DiZio, a manager with the California Department of Toxic Substances Control, says not so fast. “I don’t think we’re encouraging incineration of anything. The public outcry would be so great.”

The push for incineration hides an irony. Several decades ago, drug waste was routinely chucked into the trash and burned in hospital or city incinerators.

Then came a national campaign against air pollution. Most hospitals shut down their burners, and city incinerator managers became pickier about what they’d accept. With options restricted, hospitals began shipping more drug waste to landfills – and dumping more into toilets and sinks.

___

A few choices are expanding. Some states have passed laws to make it easier to contribute unused drugs to charity pharmacies that supply low-income patients.

Also, a small share of unused drugs is shipped back to manufacturers for credit – and incineration, waste consultants say. But the drugs are supposed to be sent back in original packaging – sometimes impractical because the packaging is discarded or damaged.

Several long-term care residences want to deploy automatic drug-dispensing machines that suppliers would refill often to reduce waste.

While not yet practical, there are several experimental technologies, such as destroying trace drugs with an electrical arc, microwaves, or caustic chemicals.

Increasingly, some bureaucrats and health professionals are suggesting that drug makers help pay costs of managing drug waste. But the pharmaceutical industry says there’s insufficient evidence of environmental harm to warrant the expense!

But impatience is mounting. Even the EPA has begun to take such suggestions seriously. Grumbles says drug makers “should do more for product stewardship and meds retrieval now.” He says it would be unwise to wait for all the proof.

For now, many health facilities, especially small ones, are put off by the cost of proper handling. Drugs deemed hazardous by the EPA – about 5 percent of the market – might cost up to $2 a pound to incinerate in a certified hazardous waste incinerator, says Vestara’s Davidner. A pound might cost 35 cents to burn in a regular trash incinerator.

Tom Clark, an executive at the American Society of Consultant Pharmacists, wonders: “When you can flush it down the toilet for free, why would you want to pay – unless there’s some significant penalties?”

© 2008 Associated Press

© Copyrighted 1997-2008
www.commondreams.org

Old Flu Shots, Then New Flu Shots. Who Knows, Maybe It’ll Work: SLU

Sunday, September 14th, 2008

One of the largest vaccine trials ever has been announced by St. Louis University. That trial will enroll 167 people.
You read that right. One of the largest vaccine trials ever will involve fewer than 170 people. If you thought that vaccines were tested over the long term and on lots of people, thing again.

Not only that, the trial appears to me as if it is an attempt to find a use for out of date, or useless old flu vaccines.

Flu vaccines are pretty much useless anyway, from where I sit, but they are valuable, at least from the point of their makers and the people who have purchased them so any use they can be put to would be welcome to those who own them.

In an article dated September 8, 2008, St. Louis University announced that it would be trying a novel approach to Pandemic Flu prevention: using an old flu vaccine approved in 2004 to prime [in other words, to irritate it-REL] in order to develop “protection” against another version of the Avian Flu when a shot for that (or a different) strain of the virus that causes Avain Flu is given.

If I did not know better, I would say that someone with a lot of money invested in ineffective, dangerous and outmoded vaccines was looking for a new use for them. You see, each year, the World Health Organization, the CDC and other organizations get together in the Spring of the year and literally guess, yes that is correct – GUESS – which strain of the so called “seasonal flu” is going to come around next fall and cause the disease we know as “the flu”.

How good are their guesses? Pretty bad. “Statisticians at CDC say that influenza is inherently unpredictable, that it’s such a random event that there’s no way that you can predict future outcomes,” said Forrest Nelson, professor of economics at the University of Iowa, says. http://scienceline.org/2007/05/23/hsu_health_flu-prediction/

Science Daily, reporting on a study published in Pediatrics, the journal of the American Academy of Pediatrics, noted “Each year’s flu vaccine needs to be designed in advance, based on which strains of virus are anticipated to be prevalent in the coming year. Because the accuracy of that prediction varies, the effectiveness of the flu vaccine also varies from year to year.” http://www.sciencedaily.com/releases/2007/09/070904072851.htm. This suggests, but does not document the CDC’s dismal record of prediction accuracy.

That record is so dismal, in fact, that a recent study which examined whether Seniors who were “properly” vaccinated were protected by the flu shot noted, ” Researchers say that older people suffering chronic conditions, such as lung disease, heart disease, diabetes, have even higher flu risk despite vaccination. Scientists thought that flu vaccine provides with 20-30% protection against pneumonia, but this research suggests that the protection level is only from 5% to 10%….Effectiveness of flu vaccine is different each year, it depends on how successful virus strain predictions for a current year will be. Flu vaccine cuts infection rates from 40% to 60% in the best cases.” http://www.emaxhealth.com/90/23622.html

But whether they are effective or not, flu vaccines are costly to make. True, they are wildly profitable if used but, when the populace figures out that they are both unsafe, unnecessary and do not provide protection, they do not use the stocks up, creating an economic blow for the highly economically motivated pharmaceutical companies.

On August 18, 2008, the St. Louis Business Journal wrote about the “quiet crisis” created by lack of increases in NIH funding. “St. Louis Business Journal — Five straight years of flat funding from the National Institutes of Health (NIH) have Washington University and Saint Louis University scrambling to fill financial gaps with other funding sources to keep biomedical research projects going.

Officials at both universities said they increasingly are using internal funds and applying for grants from private foundations and pharmaceutical companies to make up for less NIH money….Besides nonprofits, another source to which researchers have turned is pharmaceutical companies, but that’s not ideal either

“Our work doesn’t really mesh with them,” said Dr. Randy Sprague, a professor of pharmacology and physiological science at Saint Louis University. ” http://www.biospace.com/news_story.aspx?NewsEntityId=107184

Apparently, however, their work meshes well enough to try to use old flu vaccines to pump up the effect of new ones (which may or may not be made from viral strains which may or may not be causing disease in a body near you.

But you never know. It might work. Or, then again, it might not.

Of course, the impact of experimental vaccines, or extra vaccinations (94% of all available flu vaccines still contain mercury and all of them contain several (or all of the following): bits of fetal and animal tissue, “stealth viruses” which can cause cancer and other potentially lethal diseases, aluminum hydroxide (associated with Alzheimer’s Disease and especially toxic in the presence of fluoride), alumino-fluoride complexes, Polysorbate 80 (known to cause sterility), MSG (a brain irritant), mercury, formaldehyde, mixtures of viruses and bacteria, sometimes dead or inactivated. None of the vaccines have been subjected to any long-term safety trials (longer than a few weeks). Most were only studied for a few days and then approved if nothing untoward was detected by the Medical Advisory Committees, many of whom had large share-holdings or other vested interests in the vaccine companies, as recently revealed in US Congressional hearings.” according to Mike Godfrey MBBS, FACAM, FACNEM. http://www.healthy.co.nz/healthy-developments-news-item-138.html

The race to vaccinate against everything anyone, adult or child, could possibly experience began when vaccine manufacturers decided to use the US Congress to build a bulwark against the tremendous losses they were incurring by having to compensate parents for the damages their vaccines were doing to children. “By the 1970s, the manufacturers were losing very costly court actions for vaccine-damaged infants. They successfully lobbied the US Congress by threatening to stop manufacture, and in 1986, Congress gave them immunity from prosecution. This unique legislation allowed a commercial organization total freedom to start developing vaccines for all childhood illnesses. It also resulted in a massive commercial drive to mandate vaccination for every child before entering school.” http://www.healthy.co.nz/healthy-developments-news-item-138.html
And, of course, once the child hood vaccination market had been secured, adults, especially healthy adults, were the next market.

Whether for use in children or adults, however, vaccines and their toxic components, have never, repeat, never, been tested for safety in combination. That means that their dangers are less than unknown. Since vaccine manufacturers are totally protected from product liability, at least in the US, there is no reason for a manufacturer to spend money making the vaccines safe or testing them to make sure that they are, at the very least, not harmful.

So it is not outside the realm of possibility that this “largest vaccine trial ever” is just another ploy to make more money from vaccine stocks. Whether or not that is the motivation behind this “largest vaccine trial ever”, there are so many distressing aspects to the trial it is hard to know where to begin. A good place might be not to take flu vaccines!

Yours in health and freedom,
Yours in health and freedom,
Dr. Rima
Rima E. Laibow, MD
Medical Director
Natural Solutions Foundation
www.HealthFreedomUSA.org
www.GlobalHealthFreedom.org
www.NaturalSolutionsFoundation.org
www.Organics4U.org
www.NaturalSolutionsMedia.tv
www.NaturalSolutionsMarketPlace.org


Pandemic Preparation: SLU Launches Avian Flu Study

NIH-Funded Study Examines Combining Stockpiled and New Vaccines
Nancy Solomon
314.977.8017
solomonn@slu.edu
September 08, 2008

Pandemic Preparation: SLU Launches Avian Flu Study
NIH-Funded Study Examines Combining Stockpiled and New Vaccines

ST. LOUIS — Saint Louis University School of Medicine seeks volunteers for one of the largest avian flu clinical trials in the United States to test a new vaccine approach to prevent the disease.

The study will test whether an injection of an FDA-approved avian flu vaccine created in 2004 can “prime” the body’s immune system so a second shot of a different avian flu vaccine can protect against avian flu infection. The second vaccine is an investigational vaccine, which has not yet been given to people.

“This study will answer several scientific questions, but the most important one is whether you can prime with one strain of influenza vaccine and boost the body’s immune system with another,” said Robert Belshe, M.D., director of the Center for Vaccine Development at Saint Louis University School of Medicine.

Vaccines protect against influenza by triggering the body to produce antibodies against infection. The study will examine the vigor of the body’s antibody response and the safety of the vaccines.

Creating an effective vaccine for the avian flu is challenging. Like any other influenza bug, the avian flu virus — known as H5 — is constantly evolving. In addition, two doses of vaccine are likely to be needed to prevent avian flu infection, said Belshe, who is the study’s principal investigator.

Avian flu occurs in birds, and in rare instances has crossed the species barrier to infect people. As of June 2008, the World Health Organization reported 385 human cases of avian flu and 243 deaths in Asia, Europe and Africa. The virus has not yet changed so it can be spread easily between people.

Public health experts are concerned that the avian flu could become the next influenza pandemic — or outbreak of disease that sweeps around the globe, causing millions of deaths worldwide — because previous outbreaks have been started by bird viruses. Consequently researchers are focused on finding a vaccine to protect against avian flu.

“Although many years have passed since the last major pandemic, the serious threat of pandemic influenza remains,” Belshe said.

“So far there has been no substantial leap between the bird species and humans. However other pandemics have started when the organism jumps between species and we’re worried it will happen again. A few genetic changes can occur in the virus and it would become highly infectious to humans. We’re trying to prepare.”

Saint Louis University is the lead site of the research, which is sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health and will include up to five study sites. Of the 500 volunteers who are being recruited nationally, up to 167 people will be enrolled at SLU’s NIAID-funded Vaccine and Treatment Evaluation Unit (VTEU).

The study involves four to nine visits to the VTEU and overall the study lasts six to 12 months, depending upon the group to which a participant is randomly assigned.

Potential study volunteers must be healthy, between 18 and 49 years of age, not pregnant and not allergic to eggs.

Participants will receive two vaccines — one or two doses of the 2004 avian flu vaccine that currently is stockpiled; one or two doses of the investigational vaccine that matches a different strain of the avian flu; or both vaccines.

For more information about enrolling in the study, please call the Saint Louis University VTEU at (314) 977-6333 or email vaccine@slu.edu.

Established in 1836, Saint Louis University School of Medicine has the distinction of awarding the first M.D. degree west of the Mississippi River. Saint Louis University School of Medicine is a pioneer in geriatric medicine, organ transplantation, chronic disease prevention, cardiovascular disease, neurosciences and vaccine research, among others. The School of Medicine trains physicians and biomedical scientists, conducts medical research, and provides health services on a local, national and international level.

Vaccine Silly Season Heats Up: Vaccinate Children to Save Life Years!

Sunday, September 14th, 2008

The heat is on: against a growing background beat of “Pandemic’s nearly here, pandemic’s nearly here!” the repeated refrain of “Vet more vaccinations, get more shots!” is getting louder, too.

This time, we have a speculative paper that strikes me as absurd in which children are placed at high risk for getting vaccinated with yet more untested, potentially dangerous and very, very profitable vaccinations. In this case, the call is for saving the lives of children by vaccinating them with vaccines which contain deadly poisons like mercury, formaldehyde, fetal DNA, steal viruses, fluoride, chrolides, aluminum, etc., for a disease whose impact is vastly overstated (see “Flu Shot Does Not Reduce Risk of Death” following and not particularly the analysis of statistical conclusions about the death rate from flu. The highly absurd figure of 36,000 deaths per year from flu is used to sell flu vaccines and fear. But all, that’s right, all, deaths from pneumonia or any other possibly flu-related cause, whether it is or is not actually related to flu, is counted as a flu death in the grim sales pitch: get vaccinated or die.
As this second article cited shows, the reality, when examined closely, is nowhere near the puffery.
Well, what would you expect from a propaganda campaign?

Yours in health and freedom,
Dr. Rima
Rima E. Laibow, MD
Medical Director
Natural Solutions Foundation
www.HealthFreedomUSA.org
www.GlobalHealthFreedom.org
www.NaturalSolutionsFoundation.org
www.Organics4U.org
www.NaturalSolutionsMedia.tv
www.NaturalSolutionsMarketPlace.org

Vaccinating Younger Population Minimizes Life-Years Lost to Influenza

NEW YORK (Reuters Health) Sept 05 – Shifting the current vaccination strategy to target younger populations would reduce the number of years of life lost (YLL) to influenza, according to a report in the August 1st issue of The Journal of Infectious Diseases.

Vaccination allocation policy has been the subject of debate in light of several issues, among them the criticism by bioethicists of the inherent axiom that any life lost has the same value, regardless of the age of the deceased, the authors explain.

Dr. Mark A. Miller from the National Institutes of Health, Bethesda, Maryland, and colleagues sought to provide an alternative quantitative tool to help guide pandemic vaccine priority setting and achieve the greatest possible population impact, by preventing the loss of as many years of life as possible.

For a 1918-like pandemic scenario, in which most YLL occur for the younger age groups, the optimal vaccination group comprises people younger than 45 years, according to the models employed.

For a 1957-like epidemic, in which YLL were similar for older and middle age groups, it is unclear whether vaccinating the middle-age group would be better than vaccinating seniors, leading the investigators to conclude “that these age groups would be equally good choices.”

For a mild 1968-like influenza epidemic, the researchers note, vaccinating people 45 to 64 years old represents the optimal strategy for minimizing YLL.

“Our estimation is not an endorsement of any particular policy but highlights how the choice of health outcome metrics such as YLL can influence the prioritization of age groups to vaccinate in pandemic settings,” the authors explain. “It also shows that the vaccine priority scheme for seasonal influenza is not optimized to mitigate the impact of pandemic influenza.”

“These results suggest the need for pandemic plans to have an element of flexibility that allows the prioritization of age groups for immunization at the start of a pandemic to be modified as age-specific epidemiological data on the novel virus become available in real time,” the researchers conclude.

“Equally important, the question of who should be vaccinated first needs to be debated and reasoned through now, before the onset of a public health emergency, while we have the time to reflect on which decision-making metric is the most appropriate,” they add.

J Infect Dis 2008;198:305-311.

Flu Shot Does Not Reduce Risk Of Death, Research Shows

ScienceDaily (Aug. 31, 2008) — The widely-held perception that the influenza vaccination reduces overall mortality risk in the elderly does not withstand careful scrutiny, according to researchers in Alberta. The vaccine does confer protection against specific strains of influenza, but its overall benefit appears to have been exaggerated by a number of observational studies that found a very large reduction in all-cause mortality among elderly patients who had been vaccinated.

The study included more than 700 matched elderly subjects, half of whom had taken the vaccine and half of whom had not. After controlling for a wealth of variables that were largely not considered or simply not available in previous studies that reported the mortality benefit, the researchers concluded that any such benefit “if present at all, was very small and statistically non-significant and may simply be a healthy-user artifact that they were unable to identify.”

“While such a reduction in all-cause mortality would have been impressive, these mortality benefits are likely implausible. Previous studies were likely measuring a benefit not directly attributable to the vaccine itself, but something specific to the individuals who were vaccinated—a healthy-user benefit or frailty bias,” said Dean T. Eurich,Ph.D. clinical epidemiologist and assistant professor at the School of Public Health at the University of Alberta. “Over the last two decades in the United Sates, even while vaccination rates among the elderly have increased from 15 to 65 percent, there has been no commensurate decrease in hospital admissions or all-cause mortality. Further, only about 10 percent of winter-time deaths in the United States are attributable to influenza, thus to suggest that the vaccine can reduce 50 percent of deaths from all causes is implausible in our opinion.”

Dr. Eurich and colleagues hypothesized that if the healthy-user effect was responsible for the mortality benefit associated with influenza vaccination seen in observational studies, there should also be a significant mortality benefit present during the “off-season”.

To determine whether the observed mortality benefits were actually an effect of the flu vaccine, therefore, they analyzed clinical data from records of all six hospitals in the Capital Health region in Alberta. In total, they analyzed data from 704 patients 65 years of age and older who were admitted to the hospital for community-acquired pneumonia during non-flu season, half of whom had been vaccinated, and half of whom had not. Each vaccinated patient was matched to a non-vaccinated patient with similar demographics, medical conditions, functional status, smoking status and current prescription medications.

In examining in-hospital mortality, they found that 12 percent of the patients died overall, with a median length of stay of approximately eight days. While analysis with a model similar to that employed by past observational studies indeed showed that patients who were vaccinated were about half as likely to die as unvaccinated patients, a finding consistent with other studies, they found a striking difference after adjusting for detailed clinical information, such as the need for an advanced directive, pneumococcal immunizations, socioeconomic status, as well as sex, smoking, functional status and severity of disease. Controlling for those variables reduced the relative risk of death to a statistically non-significant 19 percent.

http://www.sciencedaily.com/releases/2008/08/080829091323.htm

How Much Is A Baby’s Life Worth in A Clinical Trial?

Thursday, September 4th, 2008

Big Pharma is all heart. Here is a striking example of its deep concern for our collective and individual well being: In New Delhi, 49 babies died in clinical trials in just 30 months. That’s one baby every 0.61 months, a little over half.
Did no one notice? Did no one want to give up the payments they were getting? How much as the premier All India Institute of Medicine getting per baby? Who was getting it?
How many of the responsible people will go to jail?
What do you learn in this type of trial from a baby? Or are they simply the most vulnerable and helpless group so they make great experimental subjects.
I have a lot more questions, and I bet you do, too.
But the answers that are clear are pretty grim. I am reminded of the Polish vagrants, more than 300 of them, who for $1 or $2 were injected with the Sanofi-Pasteur vaccine. That dollar cost many of them their lives and the doctors and nurses involved are on trial for murder (as is a sister company, Sanofi Aventis, for homicide because of the contaminated Hepatitis B Vaccine they were given.
The stories go on and on and on of Big Pharma and the Illness Care industry using us as their guinea pigs wth no regard for us and our well-being.
Be warned. The next time you hear that a vaccine or a pharmaceutical is good for you, ask if the pronoun is correct or if what you are really being told is “the Vaccine or pharmaceutical is good for ME, the doctor or the hospital or the Drug company.”
Yours in health and freedom,
Dr. Rima
Rima E. Laibow, MD
Medical Director
Natural Solutions Foundation
www.HealthFreedomUSA.org
www.GlobalHealthFreedom.org
www.NaturalSolutionsFoundation.org
www.Organics4U.org
www.NaturalSolutionsMedia.tv
www.NaturalSolutionsMarketPlace.org

49 babies died during clinical trials at AIIMS
Sunday, August 17, 2008
New Delhi: As many as 49 babies have died during clinical trials at the premier All India Institute of Medical Sciences (AIIMS) during the last two-and-a-half years, the reply to a Right to Information (RTI) query has revealed.

The AIIMS paediatrics department conducted 42 sets of trials on 4,142 babies – 2,728 of them below the age of one – since Jan 1, 2006.

Forty-nine babies died during the trials. AIIMS says the deaths amounted to a 1.18 percent mortality rate, according to its reply to the RTI query.

“A total of 49 deaths corresponding to 1.18 percent mortality among the enrolled patients were recorded in the studies. These include deaths both in the control and intervention groups, as per the designs of individual studies,” the reply says.

The reasons for the babies’ deaths, their ages or their gender are not contained in the reply – since these were not specifically asked by the applicant, Rahul Verma, founder of NGO Uday Foundation for Congenital Defects and Rare Blood Groups.

Verma, in fact, had filed separate queries with the same set of questions with the paediatrics department and the paediatrics surgery department. He says he received an unsatisfactory reply from the latter and is going to file an appeal in the case.

Clinical trials are research studies that test how well new medical formulations work on people. Each study attempts to find better ways to prevent, screen for, diagnose, and treat a disease.

If carefully conducted, clinical trials are the safest and fastest way of finding treatments that work.

In reply to a query on who the five top funding agencies for the trials were, AIIMS named the institute itself, the Indian Council of Medical Research (ICMR), the Department of Biotechnology (DBT), the World Health Organisation (WHO) and the Johns Hopkins Bloomberg School of Public Health in the US.

Five foreign-manufactured medicines were tested during the trials. They were:

* Zinc tablets for treating Zinc deficiency and serving as a nutritional supplement,

* Olmesartan and Valsartan for treating blood pressure related problems,

* Rituximab for treating chronic focal encephalitis, a condition affecting the brain, and

* Gene-activated human glucocerebrosidase – for treating Gaucher disease that affects the liver.

In reply to another query, AIIMS said that before conducting the trials, it had taken clearance from its own Ethics Committee, the Health Ministry Steering Committee (HMSC) on ethics and the National Ethics Committees of ICMR and DBT.

Verma, however, maintained that there were legal and ethical lacunae in the system as permissions had to be sought from different agencies depending on the nature of the trials.
http://news.indiainfo.com/2008/08/17/0808171932_49_babies_died_during_clinical_trials_at_aiims_in_last_30_months.html

Mad Cow Madness at USDA

Thursday, September 4th, 2008

Irrational behavior, I have learned over many years as a psychiatrist, is usually meaningful and makes sense if you understand the underlying premise. Failing insanity, the underlying premise is usually a closely guarded secret. Once that secret is out in the open, the formerly irrational behavior makes sense.

So what is the secret at the USDA which makes it behave irrationally when a small meat packer wants to test each and every one of its cows to prove that its product, beef, is safe to eat? Why does the US Government, now backed up by its Court system, adamantly refuse to allow Creekstone Farms to assure its potential customers that its beef is safe and free of this devastating disease?

Could it be because there is so much Mad Cow disease in the rest of the American meet supply?
Read this astonishing and horrifying story below.
Yours in health and freedom,
Dr. Rima
Rima E. Laibow, MD
Medical Director
Natural Solutions Foundation
www.HealthFreedomUSA.org
www.GlobalHealthFreedom.org
www.NaturalSolutionsFoundation.org
www.Organics4U.org
www.NaturalSolutionsMedia.tv
www.NaturalSolutionsMarketPlace.org


Court bars Meatpacker Tests for Mad Cow

By Charles Abbott
Fri Aug 29, 2008
WASHINGTON (Reuters) – The Agriculture Department is within bounds to bar meatpackers from testing slaughter cattle for mad cow disease, a U.S. Court of Appeals panel said in a 2-1 ruling on Friday.
Creekstone Farms Premium Beef LLC, a small Arkansas packer, filed suit on March 23, 2006, to gain access to mad-cow test kits. It said it wanted to test every animal at its plant to assure foreign buyers that the meat was safe to eat.
Three U.S. cases of mad cow disease, a fatal neurological infection, have been reported, the last in March 2006. People can contract a human version of the disease by eating infected meats. Most nations banned U.S. beef after the first case, in December 2003, but trade has been restored for the most part.
In a 25-page ruling, Appellate Judges Karen Henderson and Judith Rogers said USDA has authority under the 1913 Virus-Serum-Toxin Act to prevent sale of mad-cow test kits to meatpackers. USDA interprets the law to control products for “prevention, diagnosis, management or care of diseases of animals.”
David Sentelle, chief judge of the District of Columbia appeals circuit, dissented from the decision. He said USDA “exceeds the bounds of reasonableness” for a law enacted to prevent the sale of ineffective animal medicine.
USDA allows the mad-cow test kits to be sold only to laboratories that it approves. It says the tests should not be used as a marketing tool and the cattle that comprise the bulk of the meat supply are too young to be tested reliably.
Two large export markets, Japan and South Korea, accept beef only from younger U.S. cattle. Mad cow is found mostly in older cattle. Its incubation period is two to eight years.
Creekstone said it lost $200,000 a day due to reduced U.S. beef exports when it filed its lawsuit.
In its lawsuit, Creekstone argued the 1913 law could not be invoked to prevent use of products like “rapid test” kits for mad cow disease and the kits were not a “treatment” for livestock.
U.S. District Judge James Robinson had ruled in March 2007 that USDA could not control mad cow tests because they are not a treatment for animals.
The United States applies a number of safeguards against mad cow, formally named bovine spongiform encephalopathy. They include a ban on using cattle parts in feed and requirements for packers to remove at slaughter the materials most likely to carry the mad-cow agent — the brain, spinal column and nervous system tissue.
(Editing by Walter Bagley)
http://www.reuters.com/article/email/idUSN2928450820080829?pageNumber=1&virtualBrandChannel=10003